Aldeyra Therapeutics, Inc. (ALDX) Financials

ALDX Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 147.3 million 24.3 million
2023-06-30 155.6 million 25.7 million
2023-03-31 168.2 million 31.0 million
2022-12-31 181.3 million 30.3 million

ALDX Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -8.0 million 789216
2023-06-30 -13.4 million 1.6 million
2023-03-31 -9.4 million 4.2 million
2022-12-31 -11.2 million 2.8 million

ALDX Net Income

No data available :(

ALDX Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 143.3 million - 65628
2023-06-30 151.7 million - 129785
2023-03-31 165.0 million 15.0 million 190202
2022-12-31 174.3 million 14.9 million 249265

ALDX Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 59.0 million
2023-06-30 58.8 million
2023-03-31 58.8 million
2022-12-31 58.4 million

ALDX Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 - 7.0 million 2.6 million -
2023-06-30 - 7.0 million 3.4 million -
2023-03-31 - 11.2 million 5.6 million -
2022-12-31 16317 9.0 million 4.7 million -

ALDX Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 - 64999
2023-06-30 - 64339
2023-03-31 - 66972
2022-12-31 - 66643

ALDX

Price: $4.21

52 week price:
1.42
11.97

Earnings Per Share: -0.64 USD

P/E Ratio: -4

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 79624

Ebitda: -4.9 million

Market Capitalization: 250.3 million

Links: